Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Torben Noerup Nielsen who wrote (16450)	3/4/1998 4:19:00 PM
From: Henry Niman	Read Replies (1) \| Respond to of 32384

Torben, LGND closed up 3/8 at 15 11/16. It's closing bid was 15 5/8. Of course many are looking for a repeat of the several runs up and down that LGND has done for the past couple of years. However, in that time LGND has matured considerably. It's first profit is predicted for next year. It's first NDA is expect this quarter. It's first 4 NDAs are expected within a year. It's first FDA approval is expected this year. This year AHP is expected to enter the first product from their LGND alliance as is ABT, GLX, and possibly SBH. AGN is also expected to find a large partner and enter one or two compounds. That's a lot of first and by definition, is not history repeating.